Profil Financier
Anne Beaufour occupe actuellement le rang #1160 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $3.7 B (+$261 sur 24h).
Anne Beaufour owes her fortune to her stake in Ipsen, a French pharmaceutical giant that sells more than 25 drugs in 115 countries.
Founded in 1929 by grandfather Henri Beaufour, the family's 76% share of Ipsen was split between 3 siblings when father Albert Beaufour died in 2000.
Anne and her brother Henri now control 52% of Ipsen, which generated 2022 revenues of more than $3.4 billion.
Sister Veronica sold her 6% stake.
Anne holds a bachelor's degree in geology from the University of Paris Orsay.